Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | hypothetical protein | 0.03 | 1 | 0.5 |
Onchocerca volvulus | 0.0237 | 0 | 0.5 | |
Loa Loa (eye worm) | pax transcription factor protein 2 | 0.0237 | 0 | 0.5 |
Mycobacterium ulcerans | adenosylmethionine-8-amino-7-oxononanoate aminotransferase | 0.03 | 1 | 0.5 |
Mycobacterium tuberculosis | Probable aminotransferase | 0.03 | 1 | 0.5 |
Brugia malayi | Pax transcription factor protein 2 | 0.0237 | 0 | 0.5 |
Trichomonas vaginalis | acetylornithine aminotransferase, putative | 0.03 | 1 | 0.5 |
Mycobacterium tuberculosis | Adenosylmethionine-8-amino-7-oxononanoate aminotransferase BioA | 0.03 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 34.9 uM | Concentration inducing 50% inhibition of Human aorticsmooth muscle cell (HASMC) proliferation | ChEMBL. | 15125941 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.